Guideline for Temporary Marketing Authorization of Medicinal Gasses
Guideline for Temporary Marketing Authorization of Medicinal Gasses
","url":"http:\/\/www.efda.gov.et\/"}},"mobileHeader":{"firstSwitchPoint":990,"secondSwitchPoint":778,"firstSwitchPointHeight":80,"secondSwitchPointHeight":60},"stickyMobileHeaderFirstSwitch":{"logo":{"html":""}},"stickyMobileHeaderSecondSwitch":{"logo":{"html":""}},"content":{"textColor":"#8c95a2","headerColor":"#133d58"},"boxedWidth":"1340px","stripes":{"stripe1":{"textColor":"#dbdbdb","headerColor":"#ff9f1a"},"stripe2":{"textColor":"#333333","headerColor":"#203961"},"stripe3":{"textColor":"#000000","headerColor":"#203961"}}},"VCMobileScreenWidth":"778"};
var dtShare = {"shareButtonText":{"facebook":"Share on Facebook","twitter":"Tweet","pinterest":"Pin it","linkedin":"Share on Linkedin","whatsapp":"Share on Whatsapp","google":"Share on Google Plus"},"overlayOpacity":"85"}; /* ]]> */
Guideline for Temporary Marketing Authorization of Medicinal Gasses
Guideline for Temporary Market Authorization of Radiopharmaceuticals
Guideline for Registration of Low risk Medicines
Guideline on Remote or Virtual Inspection and Extension of GMP compliance Certificate
23.01.2025 Guidelines on procedures and data requirements for changes to approved biotherapeutic products
Guidelines-on-Reliance-for-Marketing Authorization 2024
GDPGSP and Re-call Guideline Revised Second edition
Guidance for time and temperature sensitive pharmaceutical product